• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
ALA

AROVELLA THERAPEUTICS LIMITED - Announcements

5.71% ! 9.9¢
Market Cap $118.1M  !

Arovella Therapeutics Limited is a biotechnology company. The Company is focused on... Arovella Therapeutics Limited is a biotechnology company. The Company is focused on developing its invariant natural killer T (iNKT) cell therapy platform from Imperial College London to treat blood cancers and solid tumors. The Company's lead product is ALA-101. ALA-101 is being developed as an allogeneic cell therapy, which means it can be given from a healthy donor to a patient. ALA-101 is a next-generation CAR-iNKT cell therapy that targets CD19+ B cell lymphomas and leukemias. ALA-101 consists of CAR19-iNKT cells that have been modified to produce a Chimeric Antigen Receptor (CAR) that targets CD19. CD19 is an antigen found on the surface of numerous cancer types. The Company is also engaged in expanding solid tumor treatment through its CLDN18.2-targeting technology licensed from Sparx Group. Its iNKT cells also contain an invariant T cell receptor (iTCR) that targets alpha-galactosylceramide (a-GalCer) bound CD1d, another antigen found on the surface of several cancer types.More

Announcements



ALA Application for quotation of securities - ALA14/12/22 download Created with Sketch. 24.81KB
ALA Proposed issue of securities - ALA13/12/22 download Created with Sketch. 24.51KB
ALA Change of Director's Interest Notice05/12/22 download Created with Sketch. 257.07KB
ALA Notice Under Section 708A05/12/22 download Created with Sketch. 191.8KB
ALA Application for quotation of securities - ALA05/12/22 download Created with Sketch. 24.81KB
ALA Application for quotation of securities - ALA02/12/22 download Created with Sketch. 24.98KB
ALA Proposed issue of securities - ALA01/12/22 download Created with Sketch. 24.54KB
ALA Proposed issue of securities - ALA30/11/22 download Created with Sketch. 26.21KB
ALA R&D Tax Incentive refund receivedPRICE SENSITIVE29/11/22 download Created with Sketch. 173.39KB
ALA Results of Annual General Meeting17/11/22 download Created with Sketch. 156.59KB
ALA AGM FY22 Presentation17/11/22 download Created with Sketch. 4.25MB
ALA Arovella to present at Biotech Showcase 202317/11/22 download Created with Sketch. 174.55KB
ALA Europe Patent to be granted for iNKT Cell Therapy PlatformPRICE SENSITIVE07/11/22 download Created with Sketch. 150.42KB
ALA Quarterly Appendix 4C and Activities ReportPRICE SENSITIVE31/10/22 download Created with Sketch. 673.02KB
ALA Arovella to close its Perth OroMist R&D FacilityPRICE SENSITIVE26/10/22 download Created with Sketch. 193.27KB
ALA Notice of Annual General Meeting/Proxy Form19/10/22 download Created with Sketch. 692.53KB
ALA Appendix 4G29/09/22 download Created with Sketch. 230.83KB
ALA Corporate Governance Statement29/09/22 download Created with Sketch. 190.93KB
ALA Annual Report to shareholders29/09/22 download Created with Sketch. 1.56MB
ALA ALA iNKT therapy and IMU onCARlytics - correction27/09/22 download Created with Sketch. 223.26KB
ALA Investor Presentation Imugene Arovella Therapies26/09/22 download Created with Sketch. 4.83MB
ALA Preclinical trial of ALA iNKT therapy and IMU onCARlyticsPRICE SENSITIVE26/09/22 download Created with Sketch. 219.23KB
ALA Notice Under Section 708A20/09/22 download Created with Sketch. 184.42KB
ALA Application for quotation of securities - ALA20/09/22 download Created with Sketch. 24.81KB
ALA Proposed issue of securities - ALA19/09/22 download Created with Sketch. 24.51KB
ALA Notification regarding unquoted securities - ALA15/09/22 download Created with Sketch. 26.11KB
ALA Preliminary Final ReportPRICE SENSITIVE31/08/22 download Created with Sketch. 270.88KB
ALA Application for quotation of securities - ALA01/08/22 download Created with Sketch. 24.93KB
ALA Notification of cessation of securities - ALA01/08/22 download Created with Sketch. 22.38KB
ALA Quarterly Appendix 4C and Activities ReportPRICE SENSITIVE29/07/22 download Created with Sketch. 719.11KB
ALA Letter to Option Holders14/07/22 download Created with Sketch. 185.89KB
ALA Initial Director's Interest Notice04/07/22 download Created with Sketch. 229.53KB
ALA Appointment of Mr Gary Phillips as Non-Executive Director01/07/22 download Created with Sketch. 163.13KB
ALA Final Director's Interest Notice01/07/22 download Created with Sketch. 253.87KB
ALA Notification regarding unquoted securities - ALA29/06/22 download Created with Sketch. 25.59KB
ALA Sumatriptan UpdatePRICE SENSITIVE28/06/22 download Created with Sketch. 139.38KB
ALA ZolpiMist Launch AustraliaPRICE SENSITIVE22/06/22 download Created with Sketch. 143.06KB
ALA Arovella Therapeutics Adopts WEF Framework For ESG Reporting08/06/22 download Created with Sketch. 434.61KB
ALA Board Changes07/06/22 download Created with Sketch. 140.36KB
ALA Change of Share Registry27/05/22 download Created with Sketch. 169.87KB
ALA Quarterly Appendix 4C and Activities ReportPRICE SENSITIVE28/04/22 download Created with Sketch. 552.98KB
ALA Services Agreement with Q-Gen for CAR19-iNKT manufacturePRICE SENSITIVE20/04/22 download Created with Sketch. 145.64KB
ALA Anagrelide patent for the United StatesPRICE SENSITIVE05/04/22 download Created with Sketch. 141.27KB
ALA Notice Under Section 708A25/03/22 download Created with Sketch. 185.09KB
ALA Notification regarding unquoted securities - ALA25/03/22 download Created with Sketch. 23.68KB
ALA Notification regarding unquoted securities - ALA25/03/22 download Created with Sketch. 23.69KB
ALA Application for quotation of securities - ALA25/03/22 download Created with Sketch. 24.88KB
ALA Application for quotation of securities - ALA25/03/22 download Created with Sketch. 24.84KB
ALA Proposed issue of securities - ALA17/03/22 download Created with Sketch. 26.57KB
ALA Change of Director's Interest Notice x516/03/22 download Created with Sketch. 534.61KB
ALA Notice Under Section 708A16/03/22 download Created with Sketch. 185.75KB
ALA Application for quotation of securities - ALA16/03/22 download Created with Sketch. 24.72KB
ALA Application for quotation of securities - ALA16/03/22 download Created with Sketch. 24.66KB
ALA Results of General Meeting08/03/22 download Created with Sketch. 487.3KB
ALA Update - Proposed issue of securities - ALA28/02/22 download Created with Sketch. 28.65KB
ALA Appendix 4D and Half Year ReportPRICE SENSITIVE28/02/22 download Created with Sketch. 741.52KB
ALA Arovella SPP Closed early over subscribedPRICE SENSITIVE21/02/22 download Created with Sketch. 191.73KB
ALA Notice of Extraordinary General Meeting/Proxy Form08/02/22 download Created with Sketch. 626.06KB
ALA Proposed issue of securities - ALA02/02/22 download Created with Sketch. 25.1KB
ALA Section 708A Disclosure Notice01/02/22 download Created with Sketch. 190.97KB
ALA Application for quotation of securities - ALA01/02/22 download Created with Sketch. 24.72KB
ALA Investor PresentationPRICE SENSITIVE01/02/22 download Created with Sketch. 4.95MB
ALA Becoming a substantial holder31/01/22 download Created with Sketch. 235.76KB
ALA Quarterly Appendix 4C and Activities ReportPRICE SENSITIVE31/01/22 download Created with Sketch. 758.67KB
ALA Update - Proposed issue of securities - ALA27/01/22 download Created with Sketch. 681.87KB
ALA Arovella Appoints New Cell Therapy Development Expert25/01/22 download Created with Sketch. 166.91KB
ALA Cleansing Notice - Share purchase plan24/01/22 download Created with Sketch. 188.35KB
ALA Proposed issue of securities - ALA24/01/22 download Created with Sketch. 25.13KB
ALA Proposed issue of securities - ALA24/01/22 download Created with Sketch. 26.6KB
ALA Proposed issue of securities - ALA24/01/22 download Created with Sketch. 28.62KB
ALA Proposed issue of securities - ALA24/01/22 download Created with Sketch. 25.4KB
ALA SPP Offer BookletPRICE SENSITIVE24/01/22 download Created with Sketch. 381.01KB
ALA Arovella Completes $4.57M Placement & Launches $1.5M SPPPRICE SENSITIVE24/01/22 download Created with Sketch. 206.63KB
ALA Trading HaltPRICE SENSITIVE20/01/22 download Created with Sketch. 563.82KB
ALA Final Director's Interest Notice14/01/22 download Created with Sketch. 167.76KB
ALA Arovella to present at Biotech Showcase 202211/01/22 download Created with Sketch. 140.42KB
ALA Change of Director's Interest Notice x 417/12/21 download Created with Sketch. 348.95KB
ALA Notification regarding unquoted securities - ALA17/12/21 download Created with Sketch. 27.07KB
ALA Results of Annual General Meeting16/12/21 download Created with Sketch. 487.63KB
ALA AGM FY21 PresentationPRICE SENSITIVE16/12/21 download Created with Sketch. 2.44MB
ALA Arovella licences novel monoclonal antibody from MD AndersonPRICE SENSITIVE13/12/21 download Created with Sketch. 4.59MB
ALA R&D Tax Incentive refund receivedPRICE SENSITIVE29/11/21 download Created with Sketch. 139.71KB
ALA Notification regarding unquoted securities - ALA17/11/21 download Created with Sketch. 24.75KB
ALA Notice of Annual General Meeting/Proxy Form15/11/21 download Created with Sketch. 738.53KB
ALA Change of Director's Interest Notice15/11/21 download Created with Sketch. 255.01KB
ALA Notification regarding unquoted securities - ALA11/11/21 download Created with Sketch. 25.95KB
ALA Application for quotation of securities - ALA11/11/21 download Created with Sketch. 24.84KB
ALA Initial Director's Interest Notice11/11/21 download Created with Sketch. 226.25KB
ALA Jobkeeper Payments Notification10/11/21 download Created with Sketch. 31.84KB
ALA Appointment of Dr Elizabeth Stoner as Non-Executive Director10/11/21 download Created with Sketch. 142.6KB
ALA Senior Management Change10/11/21 download Created with Sketch. 138.62KB
ALA Quarterly Appendix 4C and Activities ReportPRICE SENSITIVE27/10/21 download Created with Sketch. 681.61KB
ALA SUDA becomes Arovella Therapeutics22/10/21 download Created with Sketch. 138.16KB
ALA Chile Ministry of Health Approval Granted for ZolpiMistPRICE SENSITIVE21/10/21 download Created with Sketch. 170.74KB
ALA Results of General Meeting14/10/21 download Created with Sketch. 209.19KB
ALA GM presentationPRICE SENSITIVE14/10/21 download Created with Sketch. 2.33MB
ALA Appendix 4G and Corporate Governance Statement 202130/09/21 download Created with Sketch. 515.21KB
ALA Annual Report to shareholders30/09/21 download Created with Sketch. 1.14MB
ALA Notice of Extraordinary General Meeting/Proxy Form15/09/21 download Created with Sketch. 720.26KB
ALA Investor PresentationPRICE SENSITIVE07/09/21 download Created with Sketch. 2.1MB
ALA Application for quotation of securities - ALA
14/12/22 download Created with Sketch. 24.81KB
ALA Proposed issue of securities - ALA
13/12/22 download Created with Sketch. 24.51KB
ALA Change of Director's Interest Notice
05/12/22 download Created with Sketch. 257.07KB
ALA Notice Under Section 708A
05/12/22 download Created with Sketch. 191.8KB
ALA Application for quotation of securities - ALA
05/12/22 download Created with Sketch. 24.81KB
ALA Application for quotation of securities - ALA
02/12/22 download Created with Sketch. 24.98KB
ALA Proposed issue of securities - ALA
01/12/22 download Created with Sketch. 24.54KB
ALA Proposed issue of securities - ALA
30/11/22 download Created with Sketch. 26.21KB
ALA R&D Tax Incentive refund received
29/11/22PRICE SENSITIVE download Created with Sketch. 173.39KB
ALA Results of Annual General Meeting
17/11/22 download Created with Sketch. 156.59KB
ALA AGM FY22 Presentation
17/11/22 download Created with Sketch. 4.25MB
ALA Arovella to present at Biotech Showcase 2023
17/11/22 download Created with Sketch. 174.55KB
ALA Europe Patent to be granted for iNKT Cell Therapy Platform
07/11/22PRICE SENSITIVE download Created with Sketch. 150.42KB
ALA Quarterly Appendix 4C and Activities Report
31/10/22PRICE SENSITIVE download Created with Sketch. 673.02KB
ALA Arovella to close its Perth OroMist R&D Facility
26/10/22PRICE SENSITIVE download Created with Sketch. 193.27KB
ALA Notice of Annual General Meeting/Proxy Form
19/10/22 download Created with Sketch. 692.53KB
ALA Appendix 4G
29/09/22 download Created with Sketch. 230.83KB
ALA Corporate Governance Statement
29/09/22 download Created with Sketch. 190.93KB
ALA Annual Report to shareholders
29/09/22 download Created with Sketch. 1.56MB
ALA ALA iNKT therapy and IMU onCARlytics - correction
27/09/22 download Created with Sketch. 223.26KB
ALA Investor Presentation Imugene Arovella Therapies
26/09/22 download Created with Sketch. 4.83MB
ALA Preclinical trial of ALA iNKT therapy and IMU onCARlytics
26/09/22PRICE SENSITIVE download Created with Sketch. 219.23KB
ALA Notice Under Section 708A
20/09/22 download Created with Sketch. 184.42KB
ALA Application for quotation of securities - ALA
20/09/22 download Created with Sketch. 24.81KB
ALA Proposed issue of securities - ALA
19/09/22 download Created with Sketch. 24.51KB
ALA Notification regarding unquoted securities - ALA
15/09/22 download Created with Sketch. 26.11KB
ALA Preliminary Final Report
31/08/22PRICE SENSITIVE download Created with Sketch. 270.88KB
ALA Application for quotation of securities - ALA
01/08/22 download Created with Sketch. 24.93KB
ALA Notification of cessation of securities - ALA
01/08/22 download Created with Sketch. 22.38KB
ALA Quarterly Appendix 4C and Activities Report
29/07/22PRICE SENSITIVE download Created with Sketch. 719.11KB
ALA Letter to Option Holders
14/07/22 download Created with Sketch. 185.89KB
ALA Initial Director's Interest Notice
04/07/22 download Created with Sketch. 229.53KB
ALA Appointment of Mr Gary Phillips as Non-Executive Director
01/07/22 download Created with Sketch. 163.13KB
ALA Final Director's Interest Notice
01/07/22 download Created with Sketch. 253.87KB
ALA Notification regarding unquoted securities - ALA
29/06/22 download Created with Sketch. 25.59KB
ALA Sumatriptan Update
28/06/22PRICE SENSITIVE download Created with Sketch. 139.38KB
ALA ZolpiMist Launch Australia
22/06/22PRICE SENSITIVE download Created with Sketch. 143.06KB
ALA Arovella Therapeutics Adopts WEF Framework For ESG Reporting
08/06/22 download Created with Sketch. 434.61KB
ALA Board Changes
07/06/22 download Created with Sketch. 140.36KB
ALA Change of Share Registry
27/05/22 download Created with Sketch. 169.87KB
ALA Quarterly Appendix 4C and Activities Report
28/04/22PRICE SENSITIVE download Created with Sketch. 552.98KB
ALA Services Agreement with Q-Gen for CAR19-iNKT manufacture
20/04/22PRICE SENSITIVE download Created with Sketch. 145.64KB
ALA Anagrelide patent for the United States
05/04/22PRICE SENSITIVE download Created with Sketch. 141.27KB
ALA Notice Under Section 708A
25/03/22 download Created with Sketch. 185.09KB
ALA Notification regarding unquoted securities - ALA
25/03/22 download Created with Sketch. 23.68KB
ALA Notification regarding unquoted securities - ALA
25/03/22 download Created with Sketch. 23.69KB
ALA Application for quotation of securities - ALA
25/03/22 download Created with Sketch. 24.88KB
ALA Application for quotation of securities - ALA
25/03/22 download Created with Sketch. 24.84KB
ALA Proposed issue of securities - ALA
17/03/22 download Created with Sketch. 26.57KB
ALA Change of Director's Interest Notice x5
16/03/22 download Created with Sketch. 534.61KB
ALA Notice Under Section 708A
16/03/22 download Created with Sketch. 185.75KB
ALA Application for quotation of securities - ALA
16/03/22 download Created with Sketch. 24.72KB
ALA Application for quotation of securities - ALA
16/03/22 download Created with Sketch. 24.66KB
ALA Results of General Meeting
08/03/22 download Created with Sketch. 487.3KB
ALA Update - Proposed issue of securities - ALA
28/02/22 download Created with Sketch. 28.65KB
ALA Appendix 4D and Half Year Report
28/02/22PRICE SENSITIVE download Created with Sketch. 741.52KB
ALA Arovella SPP Closed early over subscribed
21/02/22PRICE SENSITIVE download Created with Sketch. 191.73KB
ALA Notice of Extraordinary General Meeting/Proxy Form
08/02/22 download Created with Sketch. 626.06KB
ALA Proposed issue of securities - ALA
02/02/22 download Created with Sketch. 25.1KB
ALA Section 708A Disclosure Notice
01/02/22 download Created with Sketch. 190.97KB
ALA Application for quotation of securities - ALA
01/02/22 download Created with Sketch. 24.72KB
ALA Investor Presentation
01/02/22PRICE SENSITIVE download Created with Sketch. 4.95MB
ALA Becoming a substantial holder
31/01/22 download Created with Sketch. 235.76KB
ALA Quarterly Appendix 4C and Activities Report
31/01/22PRICE SENSITIVE download Created with Sketch. 758.67KB
ALA Update - Proposed issue of securities - ALA
27/01/22 download Created with Sketch. 681.87KB
ALA Arovella Appoints New Cell Therapy Development Expert
25/01/22 download Created with Sketch. 166.91KB
ALA Cleansing Notice - Share purchase plan
24/01/22 download Created with Sketch. 188.35KB
ALA Proposed issue of securities - ALA
24/01/22 download Created with Sketch. 25.13KB
ALA Proposed issue of securities - ALA
24/01/22 download Created with Sketch. 26.6KB
ALA Proposed issue of securities - ALA
24/01/22 download Created with Sketch. 28.62KB
ALA Proposed issue of securities - ALA
24/01/22 download Created with Sketch. 25.4KB
ALA SPP Offer Booklet
24/01/22PRICE SENSITIVE download Created with Sketch. 381.01KB
ALA Arovella Completes $4.57M Placement & Launches $1.5M SPP
24/01/22PRICE SENSITIVE download Created with Sketch. 206.63KB
ALA Trading Halt
20/01/22PRICE SENSITIVE download Created with Sketch. 563.82KB
ALA Final Director's Interest Notice
14/01/22 download Created with Sketch. 167.76KB
ALA Arovella to present at Biotech Showcase 2022
11/01/22 download Created with Sketch. 140.42KB
ALA Change of Director's Interest Notice x 4
17/12/21 download Created with Sketch. 348.95KB
ALA Notification regarding unquoted securities - ALA
17/12/21 download Created with Sketch. 27.07KB
ALA Results of Annual General Meeting
16/12/21 download Created with Sketch. 487.63KB
ALA AGM FY21 Presentation
16/12/21PRICE SENSITIVE download Created with Sketch. 2.44MB
ALA Arovella licences novel monoclonal antibody from MD Anderson
13/12/21PRICE SENSITIVE download Created with Sketch. 4.59MB
ALA R&D Tax Incentive refund received
29/11/21PRICE SENSITIVE download Created with Sketch. 139.71KB
ALA Notification regarding unquoted securities - ALA
17/11/21 download Created with Sketch. 24.75KB
ALA Notice of Annual General Meeting/Proxy Form
15/11/21 download Created with Sketch. 738.53KB
ALA Change of Director's Interest Notice
15/11/21 download Created with Sketch. 255.01KB
ALA Notification regarding unquoted securities - ALA
11/11/21 download Created with Sketch. 25.95KB
ALA Application for quotation of securities - ALA
11/11/21 download Created with Sketch. 24.84KB
ALA Initial Director's Interest Notice
11/11/21 download Created with Sketch. 226.25KB
ALA Jobkeeper Payments Notification
10/11/21 download Created with Sketch. 31.84KB
ALA Appointment of Dr Elizabeth Stoner as Non-Executive Director
10/11/21 download Created with Sketch. 142.6KB
ALA Senior Management Change
10/11/21 download Created with Sketch. 138.62KB
ALA Quarterly Appendix 4C and Activities Report
27/10/21PRICE SENSITIVE download Created with Sketch. 681.61KB
ALA SUDA becomes Arovella Therapeutics
22/10/21 download Created with Sketch. 138.16KB
ALA Chile Ministry of Health Approval Granted for ZolpiMist
21/10/21PRICE SENSITIVE download Created with Sketch. 170.74KB
ALA Results of General Meeting
14/10/21 download Created with Sketch. 209.19KB
ALA GM presentation
14/10/21PRICE SENSITIVE download Created with Sketch. 2.33MB
ALA Appendix 4G and Corporate Governance Statement 2021
30/09/21 download Created with Sketch. 515.21KB
ALA Annual Report to shareholders
30/09/21 download Created with Sketch. 1.14MB
ALA Notice of Extraordinary General Meeting/Proxy Form
15/09/21 download Created with Sketch. 720.26KB
ALA Investor Presentation
07/09/21PRICE SENSITIVE download Created with Sketch. 2.1MB
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
9.9¢
Change
-0.006(5.71%)
Mkt cap ! $118.1M
Open High Low Value Volume
10.5¢ 10.5¢ 9.9¢ $100.7K 1.007M

Buyers (Bids)

No. Vol. Price($)
7 181339 9.8¢
 

Sellers (Offers)

Price($) Vol. No.
10.5¢ 491674 9
View Market Depth
Last trade - 13.03pm 11/08/2025 (20 minute delay) ?
Last
9.9¢
  Change
-0.006 ( 1.00 %)
Open High Low Volume
10.5¢ 10.5¢ 9.9¢ 659596
Last updated 13.39pm 11/08/2025 ?
ALA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.